CenTrial Logo

Natural Remedies for Parkinson's: Bacopa monnieri Extract

by


Clinical trial reveals benefits of natural remedy for Parkinson's

Parkinson's disease is a progressive neurological disorder that affects movement control. It occurs when specific nerve cells in the brain, responsible for producing dopamine, become damaged and start to die. Dopamine plays a crucial role in coordinating smooth muscle movements. Symptoms like tremors, stiffness, slow movements, and balance problems emerge as these cells decline.

Though the exact cause remains unclear, factors like genetics and environmental influences might contribute. While there's no cure, treatments like medication, physiotherapy, and lifestyle changes can manage symptoms and improve the patient's quality of life. Ongoing research offers hope for better understanding and potential future therapies.

Bacopa monnieri (L.) Wettst. is a medicinal herb also known as Brahmi. Research suggests it may improve cognitive function and support brain health. Bacopa is rich in antioxidants and beneficial compounds, making it a popular natural supplement. Bacopa monnieri has been used in traditional medicine for centuries, particularly in Ayurveda, as a memory-enhancing herb to reduce anxiety and stress. Its medicinal properties are attributed to active compounds such as bacosides, alkaloids, and flavonoids, which have antioxidant and anti-inflammatory properties.

Clinical Trial

There has been growing interest in exploring natural remedies and traditional herbs for their potential neuroprotective and therapeutic effects on Parkinson's disease. To investigate the potential efficacy of Bacopa monnieri in managing Parkinson's disease symptoms, a clinical trial was conducted. The trial involved twenty volunteers diagnosed with Parkinson's disease. They were enrolled in a primary, interventional, controlled, parallel, double-blind clinical trial. The participants were randomly assigned to receive either a commercial Bacopa monnieri extract at daily doses of 225 mg or 450 mg or a placebo.

Throughout the trial, various assessments were conducted to evaluate the effects of Bacopa monnieri extract on Parkinson's disease-related parameters. The Parkinson's Disease Quality-of-Life (PDQL) questionnaire measured the volunteers' quality of life, including physical, emotional, and social functions. Motor activity assessments were also conducted to evaluate movement improvements before treatment and 30, 60, and 90 days after treatment with the Bacopa monnieri extract or placebo.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

Results

There were no significant differences in Parkinsonian and systemic symptoms, emotional function, or social function between the groups receiving Bacopa monnieri extract and the placebo group. However, a time-dependent improvement in emotional function was observed in participants who received the higher daily dose of 450 mg Bacopa monnieri extract. Additionally, the study found a strong correlation between quality of life and motor outcomes after 30 days of treatment with Bacopa monnieri and a moderate correlation at 60 and 90 days compared to baseline. Furthermore, there was a moderate correlation between motor outcomes and Hoehn and Yahr stages at baseline.

These findings suggest that Bacopa monnieri extract may improve emotional function in patients with Parkinson's disease. However, the study's limitations, such as the small sample size, warrant further investigation through more extensive clinical trials to validate these preliminary results and fully understand the herb's therapeutic potential in managing Parkinson's disease symptoms.

Conclusion

Bacopa monnieri shows promise as a potential complementary treatment option for individuals with Parkinson's disease. Still, more extensive and rigorous research is needed to establish its efficacy and safety before it can be recommended as part of standard medical care. Patients are advised to consult their healthcare providers before incorporating new treatments into their Parkinson's disease management plan.
__________



Share this article with a friend:
     


Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Signup to be notified of clinical trials near you that match your condition

Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.